Table 2.
Choriocapillaris parameters at baseline and follow-up.
| RPD patients | Healthy controls | |||
|---|---|---|---|---|
| Baseline | 5-year follow-up | Baseline | 5-year follow-up | |
| Superior quadrant | ||||
| CC flow deficits (%) | 38.36 ± 4.34a | 45.48 ± 3.54b | 33.34 ± 2.29 | 35.83 ± 2.52 |
| Intensity mean | 103.21 ± 8.66a | 88.32 ± 5.47c | 117.33 ± 5.71 | 113.80 ± 6.30 |
| Intensity SD | 56.50 ± 3.09a | 56.56 ± 6.41 | 53.84 ± 1.82 | 52.78 ± 4.34 |
| Kurtosis | 1.67 ± 0.11 | 1.63 ± 0.10 | 1.69 ± 0.08 | 1.69 ± 0.07 |
| Ring | ||||
| CC flow deficits (%) | 36.39 ± 4.10a | 43.44 ± 2.80c | 32.29 ± 2.08 | 34.81 ± 3.12 |
| Intensity mean | 103.63 ± 8.47a | 86.71 ± 3.51c | 117.37 ± 5.73 | 114.12 ± 6.09 |
| Intensity SD | 53.31 ± 2.50 | 52.44 ± 5.14 | 52.75 ± 1.15 | 53.48 ± 1.90 |
| Kurtosis | 1.62 ± 0.09a | 1.53 ± 0.07c | 1.64 ± 0.03 | 1.67 ± 0.07 |
aSignificantly different at baseline.
bSignificantly different from baseline by two-way repeated measures ANOVA (time effect).
cSignificant between-group difference by two-way repeated measures ANOVA (interaction effect). Data are mean ± SD. Data were tested for normal distribution using Kolmogorov–Smirnov test. CC choriocapillaris, SD standard deviation, RPD reticular pseudodrusen.